Martine A Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS, sold UTHR on Aug 28, 2026
Data as of Oct 16
▼ SELL$697K1,346 shares at $518.14Martine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp
- Traded
- Aug 28, 2026
- Disclosed
- Aug 31, 2026
- Filed
- 3 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
UTHR since disclosure
+4.5%
after the sale
Similar stocks (XLV) since disclosure
+3.6%
XLV — its sector index fund
Change in closing price from Aug 31, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$391Kdisclosed Aug 31 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1.2Mdisclosed Aug 31 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$840Kdisclosed Aug 31 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$247Kdisclosed Aug 31 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$270Kdisclosed Aug 31 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$149Kdisclosed Aug 31 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$3.1Kdisclosed Aug 31 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$214Kdisclosed Aug 31 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$105Kdisclosed Aug 31 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$768Kdisclosed Aug 31 · filed 3 days after the trade